5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.16▲ | 5.14▲ | 5.14▲ | 5.50▼ | 5.48▼ |
MA10 | 5.16▲ | 5.18▲ | 5.20▼ | 5.60▼ | 5.50▼ |
MA20 | 5.19▼ | 5.32▼ | 5.44▼ | 5.52▼ | 5.32▼ |
MA50 | 5.45▼ | 5.53▼ | 5.58▼ | 5.50▼ | 5.20▼ |
MA100 | 5.55▼ | 5.56▼ | 5.49▼ | 5.17▲ | N/A |
MA200 | 5.52▼ | 5.49▼ | 5.41▼ | 4.98▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.009▲ | -0.010▼ | -0.037▼ | -0.048▼ | 0.032▲ |
RSI | 46.165▼ | 41.098▼ | 38.082▼ | 38.952▼ | 47.710▼ |
STOCH | 60.069 | 50.858 | 23.199 | 58.949 | 72.134 |
WILL %R | -27.586 | -46.154 | -73.418 | -75.859▼ | -52.800 |
CCI | 19.821 | -28.937 | -53.144 | -247.190▼ | -49.759 |
Wednesday, April 30, 2025 05:00 AM
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the "Company"), an oncology focused medical technology business seeking to transform outcomes for patients with solid tumors by integrating its innovative ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 5.02 | 5.27 | 4.98 | 5.19 | 21,043 |
30/04/25 | 5.48 | 5.8499 | 5.13 | 5.13 | 36,030 |
29/04/25 | 5.745 | 5.77 | 5.675 | 5.74 | 11,113 |
28/04/25 | 5.64 | 5.77 | 5.37 | 5.72 | 21,747 |
25/04/25 | 5.66 | 5.775 | 5.53 | 5.73 | 19,512 |
24/04/25 | 5.73 | 5.76 | 5.47 | 5.65 | 19,746 |
23/04/25 | 5.73 | 5.77 | 5.53 | 5.72 | 16,497 |
22/04/25 | 5.63 | 5.77 | 5.35 | 5.70 | 50,446 |
21/04/25 | 5.72 | 5.81 | 5.57 | 5.63 | 12,787 |
17/04/25 | 5.73 | 5.80 | 5.262 | 5.74 | 15,582 |
|
|
||||
|
|
||||
|
|